{"nct_id":"NCT01457924","title":"Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2018-05","start_date":"2011-11-01","start_date_type":null,"primary_completion_date":"2013-08-23","primary_completion_date_type":"ACTUAL","completion_date":"2015-06-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}